Milprosa™ (progesterone) – New drug approval
April 29, 2020 - The FDA approved Ferring Pharmaceuticals’ Milprosa (progesterone), to support embryo implantation and early pregnancy (up to 10 weeks post-embryo transfer) by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women up to and including 34 years of age.
Top